로딩 중...
52주 최고가 대비 83.4% 위치
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
SEC 13F 공시 기준 · 2026-Q1
SEC 13F 공시 기준 데이터입니다. 실제 현재 보유 현황과 다를 수 있으며, 투자 자문·권유·추천이 아닙니다.
| 재무 항목 | 2021년 | 2022년 | 2023년 | 2024년 | 2025년 |
|---|---|---|---|---|---|
| 주요 재무실적 (USD) | |||||
| 매출액 | - | $181.33B | $204.98B | $226.83B | $222.58B |
| 영업이익 | - | $1.65B | $1.79B | $2.13B | $2.32B |
| 당기순이익 | - | $-938.0M | $330.0M | $852.0M | $1.56B |
| 잉여현금흐름 (FCF) | - | $2.79B | $2.36B | $3.25B | $1.85B |
| 수익성 비율 | |||||
| 영업이익률 | - | 0.9% | 0.9% | 0.9% | 1.0% |
| 순이익률 | - | -0.5% | 0.2% | 0.4% | 0.7% |
| ROE (자기자본이익률) | - | 132.3% | -11.2% | -26.5% | -56.1% |
| ROA (자산이익률) | - | -2.1% | 0.8% | 1.9% | 2.9% |
| 성장성 비율 | |||||
| 매출 성장률 (YoY) | - | - | 13.0% | 10.7% | -1.9% |
| EPS 성장률 (YoY) | - | - | 129.9% | 245.0% | 87.0% |
| 투자 지표 & 가치배수 | |||||
| PER (주가수익배수) | - | - | 87.5x | 28.4x | 23.8x |
| PBR (주가순자산배수) | - | - | - | - | - |
| PSR (주가매출배수) | - | 0.1x | 0.1x | 0.1x | 0.2x |
| FCF Yield | - | 21.4% | 11.5% | 14.2% | 5.1% |
| 재무 건전성 (안정성) | |||||
| 부채비율 (D/E) | - | -7.50 | -1.59 | -1.58 | -3.07 |
| 유동비율 | - | 1.08 | 1.00 | 0.98 | 0.94 |
MOLINA HEALTHCARE INC
$179.86
$9.4B